[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA838179B - Synergistic anti-herpes compositions - Google Patents

Synergistic anti-herpes compositions

Info

Publication number
ZA838179B
ZA838179B ZA838179A ZA838179A ZA838179B ZA 838179 B ZA838179 B ZA 838179B ZA 838179 A ZA838179 A ZA 838179A ZA 838179 A ZA838179 A ZA 838179A ZA 838179 B ZA838179 B ZA 838179B
Authority
ZA
South Africa
Prior art keywords
herpes
compositions
synergistic anti
hyroxymethyl
guanine
Prior art date
Application number
ZA838179A
Other languages
English (en)
Inventor
Kendall O Smith
Original Assignee
Ens Bio Logicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ens Bio Logicals Inc filed Critical Ens Bio Logicals Inc
Publication of ZA838179B publication Critical patent/ZA838179B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA838179A 1982-11-04 1983-11-02 Synergistic anti-herpes compositions ZA838179B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/439,121 US4462986A (en) 1982-11-04 1982-11-04 Synergistic anti-herpes compositions

Publications (1)

Publication Number Publication Date
ZA838179B true ZA838179B (en) 1985-03-27

Family

ID=23743382

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA838179A ZA838179B (en) 1982-11-04 1983-11-02 Synergistic anti-herpes compositions

Country Status (10)

Country Link
US (1) US4462986A (de)
EP (1) EP0109234B1 (de)
JP (1) JPS59130223A (de)
AT (1) ATE26216T1 (de)
AU (1) AU557894B2 (de)
CA (1) CA1239093A (de)
DE (1) DE3370587D1 (de)
HK (1) HK77989A (de)
MC (1) MC1552A1 (de)
ZA (1) ZA838179B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4857316A (en) * 1984-10-03 1989-08-15 Syntex (U.S.A.) Inc. Synergistic antiviral composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
JP2525104B2 (ja) * 1992-03-24 1996-08-14 日本碍子株式会社 樹脂含浸紙コンデンサコアおよびその製造方法
US5550114A (en) 1993-04-02 1996-08-27 Thomas Jefferson University Epidermal growth factor inhibitor
FI973784A (fi) * 1997-09-25 1999-03-26 Huhtamaeki Oy Ksylitolikaramelli, erityisesti kovakaramelli
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
CA2460341A1 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
EP1674104A1 (de) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridinderivaten als antivirale Agentien gegen Flavividae, insbesonders HCV
WO2007101949A2 (fr) * 2006-03-08 2007-09-13 Biomethodes Variants de l'interferon- gamma humain (infgamma)
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2134292A1 (en) * 1971-04-30 1972-12-08 Inst Nat Sante Rech Med Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
GR76891B (de) * 1981-08-11 1984-09-04 Wellcome Found
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
EP0101441B1 (de) * 1982-02-12 1987-01-14 Syntex (U.S.A.) Inc. Antivirale zusammensetzungen

Also Published As

Publication number Publication date
AU557894B2 (en) 1987-01-15
HK77989A (en) 1989-10-06
EP0109234B1 (de) 1987-04-01
ATE26216T1 (de) 1987-04-15
EP0109234A1 (de) 1984-05-23
MC1552A1 (fr) 1984-08-31
US4462986A (en) 1984-07-31
DE3370587D1 (en) 1987-05-07
JPS59130223A (ja) 1984-07-26
AU2068183A (en) 1984-05-10
CA1239093A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
ZA838179B (en) Synergistic anti-herpes compositions
HK1094148A1 (en) Synergistic therapeutic compositions and methods
IL99792A0 (en) Synergistic agents
GR3024699T3 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
GB8914060D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL100195A0 (en) Use of xanthines for the preparation of a medicament having immuno suppressing activity
GB8914061D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
GB8914062D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
AR242013A1 (es) Un procedimiento para el control de la proliferacion algacea en un sistema acuoso.
GB2108383B (en) Compound and composition for use against herpes virus
AU4257896A (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpes virus infections
EP0456334A3 (en) Heribicidal composition with synergistic activity
ZA893261B (en) Synergistic combinations and their use as therapeutic agents
IL109993A0 (en) Ipsapirone medicament formulation
DE3590054D2 (en) Therapeutic agent for combating infections caused by herpes viruses
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.
GB9122698D0 (en) Synergistic agents
IE852286L (en) Contraceptive synergistic association
NZ210495A (en) Purine derivatives and pharmaceutical compositions
GB9300650D0 (en) Synergistic compositions for treating the skin
IE822751L (en) Antiviral agents, their preparations and use
PH25138A (en) Synergistic agent for the protection of wood
ZA83378B (en) Beta-lactam antibacterial agents,their preparation and use